Sign in

    Sahil Guttal

    Research Analyst at RBC Capital Markets

    Sahil Guttal is an analyst at RBC Capital Markets specializing in equity research, with a focus on industrial companies such as AMETEK Inc. He has contributed to investment research by engaging directly with corporate management, but publicly available performance metrics and ranking data are currently limited. Guttal began his career in financial analysis before joining RBC Capital Markets, and his specific credentials and professional registrations have not been disclosed in public records. His career reflects active participation in company earnings calls and sector coverage within industrials.

    Sahil Guttal's questions to AMETEK INC/ (AME) leadership

    Sahil Guttal's questions to AMETEK INC/ (AME) leadership • Q4 2024

    Question

    Sahil Guttal, on for Deane Dray of RBC Capital Markets, asked for context on the $85 million in planned growth investments for 2025, including its segment split, and inquired about the outlook for the New Product Vitality Index.

    Answer

    Executive David Zapico explained the $85 million in incremental growth investments for 2025 is similar to 2024's $90 million. The spend is roughly two-thirds R&D and one-third sales and marketing, with a bias toward the larger EIG segment. He noted the Vitality Index was very strong at 30% in Q4, reflecting a successful new product engine that supports pricing power and is expected to pay off in the coming year.

    Ask Fintool Equity Research AI